当前位置：
X-MOL 学术
›
JAMA Intern. Med.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Association of Insurance Gains and Losses With Access to Prescription Drugs
JAMA Internal Medicine ( IF 22.5 ) Pub Date : 2017-10-01 , DOI: 10.1001/jamainternmed.2017.4011 K. Robin Yabroff 1 , James Kirby 2 , Marc Zodet 2
JAMA Internal Medicine ( IF 22.5 ) Pub Date : 2017-10-01 , DOI: 10.1001/jamainternmed.2017.4011 K. Robin Yabroff 1 , James Kirby 2 , Marc Zodet 2
Affiliation
|
Association of Insurance Gains and Losses With Access to Prescription Drugs Prescription drugs can effectively treat many diseases, improving quality of life, life expectancy, and population health. However, prescription drug spending has been rising rapidly in the United States1 resulting in concerns about affordability and patient access. Health insurance is strongly associated with prescription drug access in cross-sectional studies,2,3 but estimates may partly reflect differences between individuals with and without insurance, rather than effects of insurance coverage. To address this limitation, we used longitudinal data from the nationally representative Medical Expenditure Panel Survey (MEPS) to assess the effects of insurance gains and losses on prescription drug access.
中文翻译：
获得处方药的保险收益和损失的关联
保险收益和损失与获得处方药的关联 处方药可以有效治疗多种疾病，提高生活质量、预期寿命和人口健康。然而，处方药支出在美国 1 迅速增长，导致人们对可负担性和患者可及性的担忧。在横断面研究中，健康保险与处方药的获取密切相关，2,3 但估计可能部分反映了有保险和没有保险的个人之间的差异，而不是保险范围的影响。为了解决这一限制，我们使用来自全国代表性医疗支出小组调查 (MEPS) 的纵向数据来评估保险收益和损失对处方药获取的影响。
更新日期：2017-10-01
中文翻译：
获得处方药的保险收益和损失的关联
保险收益和损失与获得处方药的关联 处方药可以有效治疗多种疾病，提高生活质量、预期寿命和人口健康。然而，处方药支出在美国 1 迅速增长，导致人们对可负担性和患者可及性的担忧。在横断面研究中，健康保险与处方药的获取密切相关，2,3 但估计可能部分反映了有保险和没有保险的个人之间的差异，而不是保险范围的影响。为了解决这一限制，我们使用来自全国代表性医疗支出小组调查 (MEPS) 的纵向数据来评估保险收益和损失对处方药获取的影响。
京公网安备 11010802027423号